Abstract
Written protocols are often employed to guide patient care. For treatment within a clinical trial, compliance with the trial protocol may be critical in ensuring efficacy and safety. Previous empirical work has established generic safety principles for reasoning about adverse events in clinical trials and their formalisation has been applied in a decision support system for managing treatment plans in oncology. The same generic knowledge can be reused to generate specific safety clauses when designing new treatment plans. Typically, clinicians devise trial protocols relatively infrequently and so software aids, especially those assisting with regulatory/safety conformance, will encourage more effective use of their time. A similar approach to the formalisation of safety knowledge in the control of hazardous industrial processes is discussed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- EEC note for guidance: good clinical practice for trials on medicinal products in the European Community. CPMP Working Party on Efficacy of Medicinal Products. Pharmacol Toxicol. 1990 Oct;67(4):361–372. doi: 10.1111/j.1600-0773.1990.tb00847.x. [DOI] [PubMed] [Google Scholar]
- Hammond P., Harris A. L., Das S. K., Wyatt J. C. Safety and decision support in oncology. Methods Inf Med. 1994 Oct;33(4):371–381. [PubMed] [Google Scholar]
- Kent D. L., Shortliffe E. H., Carlson R. W., Bischoff M. B., Jacobs C. D. Improvements in data collection through physician use of a computer-based chemotherapy treatment consultant. J Clin Oncol. 1985 Oct;3(10):1409–1417. doi: 10.1200/JCO.1985.3.10.1409. [DOI] [PubMed] [Google Scholar]
- Litzelman D. K., Dittus R. S., Miller M. E., Tierney W. M. Requiring physicians to respond to computerized reminders improves their compliance with preventive care protocols. J Gen Intern Med. 1993 Jun;8(6):311–317. doi: 10.1007/BF02600144. [DOI] [PubMed] [Google Scholar]
- Rowinsky E. K., Gilbert M. R., McGuire W. P., Noe D. A., Grochow L. B., Forastiere A. A., Ettinger D. S., Lubejko B. G., Clark B., Sartorius S. E. Sequences of taxol and cisplatin: a phase I and pharmacologic study. J Clin Oncol. 1991 Sep;9(9):1692–1703. doi: 10.1200/JCO.1991.9.9.1692. [DOI] [PubMed] [Google Scholar]
- Wyatt J. C., Altman D. G., Heathfield H. A., Pantin C. F. Development of Design-a-Trial, a knowledge-based critiquing system for authors of clinical trial protocols. Comput Methods Programs Biomed. 1994 Jun;43(3-4):283–291. doi: 10.1016/0169-2607(94)90081-7. [DOI] [PubMed] [Google Scholar]
- van der Lei J., Musen M. A. A model for critiquing based on automated medical records. Comput Biomed Res. 1991 Aug;24(4):344–378. doi: 10.1016/0010-4809(91)90034-t. [DOI] [PubMed] [Google Scholar]